Sermorelin

Sermorelin is a synthetic 29-amino acid peptide analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release endogenous growth hormone.

Brief glance

The primary outcome is Performance, but it's also used for Anti-Aging, Metabolic. This compound is considered a Peptide. It may be compounded in 503A pharmacies where allowed. It is not listed under a DEA schedule.

Overview

Sermorelin is a synthetic 29-amino acid peptide that mimics growth hormone-releasing hormone (GHRH), stimulating the pituitary gland to enhance natural human growth hormone (hGH) production. Typical dosages range from 200-500 mcg daily via subcutaneous injection before bedtime, often starting at 200-300 mcg with adjustments based on response, following a 5 nights on, 2 off protocol for 3-6 months. It supports anti-aging benefits like improved energy, sleep, and body composition under medical supervision.

Sermorelin acetate is a synthetic 29-amino acid peptide analog of the first segment of naturally occurring human growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on the pituitary gland, stimulating the pulsatile release of endogenous growth hormone (GH) and subsequently increasing insulin-like growth factor 1 (IGF-1) levels, which supports growth, metabolism, and regenerative processes. Primarily used to treat growth hormone deficiency in children and adults, it offers a more physiological alternative to direct recombinant GH injections by mimicking natural hormone rhythms and avoiding constant exposure. Originally FDA-approved in the 1990s under brand names like Geref, it was discontinued commercially for business reasons but remains available as a compounded medication via subcutaneous injection. Its use for anti-aging in healthy individuals lacks FDA approval and proven efficacy.

Benefits

Sermorelin stimulates endogenous growth hormone (GH) release from the pituitary gland, primarily used to diagnose and treat growth hormone deficiency in children, where clinical studies show significant increases in height velocity sustained over 12 to 36 months with daily subcutaneous administration.¹,² In adults, it is sometimes applied off-label for GH deficiency, with evidence indicating potential improvements in lean body mass, growth rate, and sleep quality.¹,³ Research supports its role in enhancing tissue repair and metabolic parameters, such as reduced abdominal adiposity, though definitive data for anti-aging or healthy adult use remain limited.¹,³

Side effects

Sermorelin, a synthetic growth hormone-releasing hormone analog administered via subcutaneous injection, commonly causes mild, transient side effects at the injection site such as redness, swelling, pain, irritation, itching, or sensitivity, which often resolve with proper technique and site rotation.¹,⁴,⁵ Other frequent side effects include headache, nausea, dizziness, flushing, trouble swallowing, sleepiness, and trouble sitting still, typically appearing early in treatment and improving over time.¹,⁴,⁵ Less common effects may involve mood changes, fatigue, taste alterations, rash, water retention, joint pain, or sleep disturbances, while rare serious reactions like allergic responses (e.g., difficulty breathing), chest pain, or insulin resistance warrant immediate medical attention.¹,⁴,⁶,⁷ Key safety considerations include monitoring for growth hormone excess risks such as hypertension, cardiac issues, or diabetes, especially with long-term use, and avoiding unregulated sources due to contamination hazards; patients should consult providers for allergies, proper dosing, and symptom tracking.⁵,⁶ Overall, sermorelin is generally well-tolerated under medical supervision.¹,⁸

Mechanisms of action

Sermorelin is a synthetic 29-amino acid analog of growth hormone-releasing hormone (GHRH) that binds to the growth hormone-releasing hormone receptor (GHRHR) on the pituitary gland.⁹,¹⁰,¹¹ This binding mimics the action of native GHRH, activating G proteins that stimulate adenylyl cyclase, which promotes somatotroph cell growth, growth hormone (GH) gene transcription, and pulsatile GH secretion into the bloodstream.⁹,¹⁰,¹² Unlike direct GH administration, Sermorelin's effects are regulated by negative feedback from somatostatin, producing natural episodic GH release patterns that avoid overdose risks and tachyphylaxis while preserving pituitary function.¹⁰,¹³ This leads to increased insulin-like growth factor 1 (IGF-1) production in the liver, supporting tissue repair and metabolism.¹²,¹⁴